Respiratory I Plus EQA/PT Scheme (Q4)

The Respiratory I Plus EQA will focus on the molecular detection and determination of various influenza A & B, respiratory syncytial virus strains and SARS-Cov-2. The panel is designed to represent various clinical scenarios. Participating laboratories will be expected to test each panel using their appropriate molecular methods and report their individual test results to QCMD.

Total Number of Challenges: 1
Number of Panel Members: 10
Distribution / Testing Period: Q4
Sample NA Target Source Cultured and/or Clinical material
Matrix Panel Format Transport Medium
Panel Member Target Range Covering clinical range
Panel Member Sample Volume 1.0 ml
Panel Sample Pre-treatment Requirement Ready for analysis. Treat as clinical samples and analyse accordingly.
Panel Analysis Type Qualitative
Panel Testing Evaluated by various molecular methodologies
Storage / Shipment Conditions <-20°C / Frozen on Dry-ice
Accreditation / Regulatory Status Accredited to ISO 17043
SKU: QAM204216_1B Categories: , , , Tags: ,

$1,398.42